bioRxivMicrobiologyPreprint
Persistent Staphylococcus aureus in human musculoskeletal tissues despite targeted antibiotic therapy
Benedict MoriniD, Vishwachi TripathiiD, Anne-Kathrin WoischnigiD, Joana ErdmanniD, Aya IizukaiD, Daniel BaumhoeriD, Katharina RentschiD, Loïc SauteuriD, Ewelina Magdalena BartoszekiD, Peter M KelleriD, Krittapas JantarugiD, Pablo Rivera‐FuentesiD, Baptiste HameliniD, Salome HoschiD, Kirsten MertziD, Mario MorgensterniD, Martin ClaussiD, Dirk BumanniD, Richard KüehliD, Nina KhannaiD
Abstract
Staphylococcus aureus is a leading cause of musculoskeletal infection with frequent recurrence despite surgery and antibiotic therapy. Its persistence in human tissues under antibiotic pressure remains unclear. We performed longitudinal in situ analyses of matched tissue samples before and during therapy from patients undergoing repeated surgery using advanced imaging and tissue-based metagenomics. S. aureus remained detectable in all samples--including culture-negative specimens--and whole-genome sequencing confirmed persistence of the infecting strain. Antibiotic initiation reduced bacterial burden by 1.0Slog10 bacteria/mm3 but residual loads stabilized thereafter. Quantitative imaging identified a culture detection threshold ([~]103bacteria/mm3), indicating that culture negativity reflects diagnostic sensitivity limits rather than true bacterial clearance. Persistence under antibiotic therapy was associated with high baseline burden and intracellular sequestration, whereas long-term persistence was characterized by predominantly extracellular bacteria capable of driving relapse. These findings reveal sustained tissue persistence despite apparent microbiological clearance and guide precision strategies to target resilient bacterial reservoirs.
- organism: human
- assay: metagenomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Microgeography of staphyloccoci in human tissue explains antibiotic failure
Vishwachi Tripathi, Benedict Morin, … Dirk Bumann·bioRxiv·Sep 12, 2025
- Biofilm/Persister/Stationary Phase Bacteria Cause More Severe Disease Than Log Phase Bacteria II Infection with Persister Forms of Staphylococcus aureus Causes a Chronic Persistent Skin Infection with More Severe Lesion that Takes Longer to Heal and is not Eradicated by the Current Recommended Treatment in Mice
Rebecca Yee, Yuting Yuan, … Ying Zhang·bioRxiv·Nov 29, 2018
- Prolonged lag time results in small colony variants and reflects a sub-population of persisters in vivo
C. Vulin, N. Leimer, … A. S. Zinkernagel·bioRxiv·Mar 12, 2018
- A Drug Combination Approach Targeting Both Growing Bacteria and Dormant Persisters Eradicate Persistent Staphylococcus aureus Biofilm Infection
- Quantification of within patient Staphylococcus aureus phenotypic heterogeneity as a proxy for presence of persisters across clinical presentations
J. Baer, M. Boumasmoud, … A. S. Zinkernagel·bioRxiv·Jul 27, 2021
- The Toxin Antitoxin MazEF Drives Staphylococcus aureus Chronic Infection
D. Ma, J. B. Mandell, … K. L. Urish·bioRxiv·Jun 30, 2019